Descrizione business
Formycon is a leading and independent developer of biosimilar drugs, meeting the highest quality standards, for marketing and distribution around the globe. The company spans the entire pharmaceutical value creation chain all the way through to phase III clinical trials and registration. Formycon specifically develops biosimilars to meet the stringent standards required for regulatory approval in the most highly regulated markets (EU, U.S., Japan, Canada, Australia), and positions itself as preferred partner for major pharmaceutical and generic corporations.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Stefan Glombitza |
| Consiglio di amministrazione |
| Enno Spillner, Nicola Mikulcik, Andreas Seidl |
| Consiglio di sorveglianza |
| Wolfgang Essler, Nicholas Haggar, Klaus Röhrig, Bodo Coldewey, Colin Bond |
Dati aziendali
| Name: |
Formycon AG |
| Indirizzo: |
Fraunhoferstraße 15,D-82152 Martinsried/Planegg |
| Telefono: |
+49-89-864667-100 |
| Fax: |
+49-89-864667-110 |
| E-mail: |
info@formycon.com
|
| Internet: |
www.formycon.com |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
36.20% |
| Data dell'IPO: |
20/12/2010 |
Rapporti con gli investitori
| Name: |
Sabrina Müller |
| IR telefono: |
+49-89-864667-149 |
| IR Fax: |
+ 49 89 86 46 67 110 |
| IR e-mail: |
sabrina.mueller@formycon.com
|